Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease

Kidney International

Volumn 67, Issue 1, 2005, Pages 259-264

  Stam, Frank ^a   Van Guldener, Coen ^b   Ter Wee, Piet M ^b   Jakobs, Cornelis ^b   De Meer, Kees ^b   Stehouwer, Coen D A ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

End stage renal disease; Folic acid; Homocysteine; Remethylation; Transmethylation; Transsulfuration

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; METHIONINE;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; RISK REDUCTION; VITAMIN SUPPLEMENTATION;

EID: 10944234529     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00076.x     Document Type: Article

References (24)

1. HOMOCYSTEINE STUDIES COLLABORATION: Homocysteine and risk of ischemic disease and stroke. A meta-analysis. JAMA 288:2015-2022, 2002
2. MUNTNER P, HAMM LL, KUSEK JW, et al: The prevalence of non-traditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140:9-17, 2004
3. ROBINSON K, GUPTA A, DENNIS V, et al: Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94:2743-2748, 1996
4. FRIEDMAN AN, BOSTOM AG, SELHUB J, et al: The kidney and homocysteine metabolism. J Am Soc Nephrol 12:2181-2189, 2001
5. VAN GULDENER C, KULIK W, BERGER R, et al: Homocysteine and methionine metabolism in ESRD: A stable isotope study. Kidney Int 56:1064-1071, 1999
6. VAN GULDENER C, STAM F, STEHOUWER CDA: Homocysteine in renal failure. Kidney Int 59 (Suppl 78):S234-S237, 2001
7. HOFFER LJ: Methods for measuring sulfur amino acid metabolism. Curr Opin Clin Nutr Metab Care 5:511-517, 2002
8. STAM F, VAN GULDENER C, TER WEE PM, et al: Homocysteine clearance and methylation flux rates in health and end-stage renal disease: Association with S-adenosylhomocysteine. Am J Physiol Renal Physiol 287:F215-F223, 2004
9. 6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD. J Nephrol 16:522-534, 2003
10. MASSY ZA: Reversal of hyperhomocyst(e)inaemia in chronic renal failure-Is folic or folinic acid the answer? Nephrol Dial Transplant 14:2810-2812, 1999
11. 12. Nephrol Dial Transplant 17:865-870, 2002
12. GHANDOUR H, BAGLEY PJ, SHEMIN D, et al: Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic acid. Kidney Int 62:2246-2249, 2002
13. HAUSER A-C, HAGEN W, REHAK PH, et al: Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients. Am J Kidney Dis 37:758-765, 2001
14. DURNIN JV, WOMERSLAY J: The relationship between skinfold thickness and body fat in adults of middle age. J Physiol 200:105-106, 1969
15. KAMIMURA MA, JOSE DOS SANTOS NS, AVESANI CM, et al: Comparison of three methods for the determination of body fat in patients on long-term hemodialysis therapy. J Am Diet Assoc 103:195-199, 2003
16. 6 nutritional status. J Chromatogr 342:277-284, 1985
17. 13C] methionine in human plasma by gas chromatography-negative chemical ionization mass spectrometry. J Chromatogr B Biomed Sci Appl 738:99-105, 2000
18. STORCH KJ, WAGNER DA, BURKE JF, YOUNG VR: Quantitative study in vivo of methionine cycle in humans using [methyl-2H3]- and [1-13C] methionine. Am J Physiol 255:E322-E331, 1988
19. VAN GULDENER C, JANSSEN MJFM, LAMBERT J, et al: No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients. Nephrol Dial Transplant 13:106-112, 1998
20. FINKELSTEIN JD: Methionine metabolism in mammals. J Nutr Biochem 1:228-237, 1990
21. ARNADOTTIR M, BRATTSTRÖM L, SIMONSEN O, et al: The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 40:236-240, 1993
22. BOSTOM AG, GOHH RY, BEAULIEU AJ, et al: Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial. Ann Intern Med 127:1089-1092, 1997
23. VAN GULDENER C, JANSSEN MJFM, DE MEER K, et al: Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients. J Int Med 245:175-183, 1999
24. INGROSSO D, CIMMIONI A, PERNA AF, et al: Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 361:1693-1699, 2003